FOLD FY 2020 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$261M+43.2% YoY

Gross Profit

$230M88.1% margin

Operating Income

-$247M-94.7% margin

Net Income

-$277M-106.1% margin

EPS (Diluted)

$-1.07

Cash Flow

Operating Cash Flow

-$233M

Free Cash Flow

-$237M

Stock-Based Comp.

$49M

Balance Sheet

Total Assets

$887M

Total Liabilities

$600M

Stockholders' Equity

$286M

Cash & Equivalents

$163M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$261M	$182M	+43.2%
Gross Profit	$230M	$160M	+43.4%
Operating Income	-$247M	-$304M	+18.8%
Net Income	-$277M	-$356M	+22.3%